AARUY links up with the 2025 IDF World Diabetes Conference to jointly shape the future of diabetes management
2025-04-17 18:00
From April 7th to 10th, 2025, the IDF World Diabetes Congress, the most influential event in the global diabetes field, was grandly held in Bangkok, Thailand.
As one of the pioneers in China's medical technology field, AARUY showcased its core products such as the self-developed insulin pump and participated deeply in the conference joining more than 6,300 experts, scholars and industry leaders from over 160 countries to explore new trends in diabetes prevention and control.
The 11th edition of the IDF Global Diabetes Map, released at this conference, reveals tough global trends:
· 589 milion adults (aged 2079) have diabetes, 40 percent undiagnosed, and China leads the world with 150 million patients.
· By 2050, the total number of patients is projected to soar to 853 million, with significant increases in regions such as Africa and Southeast Asia.
· Diabetes-related health spending has surpassed $1 trillion for the first time, and uneven distribution of resources has exacerbated treatment challenges in low - and middle-income countries.
· The figures serve as a wake-up call for global strategies to combat diabetes and highlight the urgency of technological innovation and collaboration.
The world's first insulin pump with dual-mode design of patch and portable designs, suitable for various scenarios such as sports and social activities, solves a series of traditional pump problems with the concept of "minimally invasive comfort".
· Ultra-small, ultra-light;
· Patented balanced indwelling soft needle solves the industry problem of foreign body sensation caused by steel needle and the large incision and easy infection of the patch insulin pump;
· 3mL large reservoir, one-time loading, convenient to use, reduces the risk of liquid contamination;
· A variety of control methods, mobile app controller/ watch controller/portable controller, choose from multiple controllers as you like.
The spark of medical innovation always bursts forth in the collision of ideas. The ladder of industry progress is often forged by working together to climb.
AARUY adheres to the concept of "openness and win-win", welcoming medical industry partners from all over the world to visit and exchange. Through various forms such as innovative technology demonstrations, solution discussions, and industry trend discussions, it has built a professional dialogue platform that spans regions and fields.
With the RuyPump, AARUY has received positive feedback from users in many countries. European experts praised the dual-mode design and minimally invasive technology for enhancing the user experience of the insulin pump. Young patients in Asia favor the convenience brought by intelligent App management. Representatives from the health departments of many countries have paid particular attention to the 3mL large reservoir and the highly adaptable design, believing that this will enhance the global accessibility of diabetes management.
Since the beginning of the insulin pump research and development, AARUY has been promoting a systematic strategic layout with a global perspective.We are well aware that the global expansion of medical devices requires not only overcoming technical barriers but also strengthening the moat of intellectual property rights.
At present, AARUY has completed trademark registration layouts in over a hundred countries, applied for multiple international patents and software Copyrights, covering the entire chain of core technologies.This forward-looking layout not only eliminates entry barriers for products to quickly enter the global market, but also safeguards innovative achievements with the international intellectual property system.
Join hands with the world to shape the future together!AARUY works with you to focus on the prevention and treatment of diabetes, lighting up the light of life with technology.
More news
